The assessment of plasma asprosin levels in acute coronary artery disease and its correlation with HEART score

The assessment of plasma asprosin levels in acute coronary artery disease and its correlation with HEART score

<b>Objective:  </b>It was aimed to compare the serum asprosin levels in patients with ischemic heart disease with healthy subjects, and to evaluate the relationship between asprosin levels with HEART score and mortality in the patients with coronary heart disease.<br /> &l...

Full description

Bibliographic Details
Main Authors:	Abdullah Algin, Serdar Özdemir, Hatice Şeyma Akça, Nihat Müjdat Hökenek, Kamil Kokulu, Mehmet Özgür Erdoğan, Önder Yumrutaş
Format:	Article
Language:	English
Published:	National Scientific Medical Center 2022-04-01
Series:	Ķazaķstannyṇ Klinikalyķ Medicinasy
Subjects:	acute chest pain asprosin HEART score
Online Access:	https://www.clinmedkaz.org/download/the-assessment-of-plasma-asprosin-levels-in-acute-coronary-artery-disease-and-its-correlation-with-11939.pdf

Similar Items

Relationship of asprosin and diabetes: a meta-analysis
by: Xiandong Zeng, et al.
Published: (2025-01-01)

Asprosin; effects and associations
by: Shakiba Hassanzadeh, et al.
Published: (2022-01-01)

Asprosin in early detection of nephropathy in type2 diabetes mellitus
by: Ola Hussein Abed Alwahid, et al.
Published: (2023-01-01)

Association of serum Asprosin concentrations with heart failure
by: Guoan Wang, et al.
Published: (2023-12-01)

Evaluation of Asprosin Hormone in Hypothyroidism Patients
by: Nidaa Ateah, et al.
Published: (2023-04-01)

Serum Asprosin Correlates with Indirect Insulin Resistance Indices
by: Małgorzata Mirr, et al.
Published: (2023-05-01)

Asprosin is positively associated with metabolic syndrome in hemodialysis patients: a cross-sectional study
by: Jiandong Zhou, et al.
Published: (2023-12-01)

The role of Asprosin in patients with dilated cardiomyopathy
by: Ming-Shien Wen, et al.
Published: (2020-09-01)

Asprosin in nonalcoholic fatty liver disease and hypothyroidism: a case-control study
by: Mona Abdel-Latif Aboul-Seoud, et al.
Published: (2024-12-01)

The protective effects of humanin in rats with experimental myocardial infarction: The role of asprosin and spexin
by: Elif Onat, et al.
Published: (2023-08-01)

Asprosin: A Novel Player in Metabolic Diseases
by: Mingyang Yuan, et al.
Published: (2020-02-01)

The role of asprosin and ceramides in the development of growth hormone deficiency in children
by: Muntadher Mohammad Al-Jubawi, et al.
Published: (2022-01-01)

Association Between Plasma Asprosin Levels and Gestational Diabetes Mellitus
by: Boz İB, et al.
Published: (2023-08-01)

Serum concentration of asprosin in new-onset type 2 diabetes
by: Shakiba Naiemian, et al.
Published: (2020-07-01)

Research progress on the role of Asprosin in germ cell development
by: XU Zhiqin, TAN Xiao
Published: (2024-04-01)

Evaluation of Plasma Asprosin Concentration in Patients with Coronary Artery Disease
by: Cengiz Güven, et al.
Published: (2022-01-01)

The Effects of Asprosin on Exercise-Intervention in Metabolic Diseases
by: Lifei Liu, et al.
Published: (2022-07-01)

Circulating levels of asprosin in children with obesity: a systematic review and meta-analysis
by: Yuwei Zhang, et al.
Published: (2024-03-01)

Leptin, Ghrelin, Irisin, Asprosin and Subfatin Changes in Obese Women: Effect of Exercise and Different Nutrition Types
by: Elif Bengin, et al.
Published: (2024-07-01)

Plasma Asprosin Concentrations are Associated with Progression of Diabetic Kidney Disease
by: Xu M, et al.
Published: (2024-06-01)

Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations
by: Lijing Ma, et al.
Published: (2024-12-01)

Investigation of serum asprosin level in patients diagnosed of polycystic ovary syndrome in adolescent age
by: Merve Gungor, et al.
Published: (2022-12-01)

The association of plasma asprosin with anthropometric and metabolic parameters in Korean children and adolescents
by: Shin-Hee Kim, et al.
Published: (2024-10-01)

Subfatin, Asprosin, Alamandine and Maresin-1 Inflammation Molecules in Cardiopulmonary Bypass
by: Hanbeyoglu O, et al.
Published: (2023-08-01)

Correlation of metabolic characteristics with maternal, fetal and placental asprosin in human pregnancy
by: Thorben Hoffmann, et al.
Published: (2022-03-01)

Evaluation of the relationship between neonatal serum asprosin levels and anthropometric measurements in newborns of mothers with and without gestational diabetes mellitus
by: Emine Esin Yalınbaş, et al.
Published: (2023-10-01)

Increased serum asprosin is correlated with diabetic nephropathy
by: Rui Wang, et al.
Published: (2021-05-01)

Asprosin promotes vascular inflammation via TLR4-NFκB-mediated NLRP3 inflammasome activation in hypertension
by: Rui Ge, et al.
Published: (2024-06-01)

ASPROSIN: A NOVEL BIOMARKER OF TYPE 2 DIABETES MELLITUS
by: Asmaa Elnagar, et al.
Published: (2018-11-01)

The impaired response of circulating asprosin concentrations to glucose levels fluctuation may be one of the causes of type 2 diabetes – a narrative review
by: Paulina Trojanowska, et al.
Published: (2020-09-01)

Review of Asprosin as new Biomarker for diagnosis different Diseases
by: safaa ehssan, et al.
Published: (2023-12-01)

Asprosin-neutralizing antibodies as a treatment for metabolic syndrome
by: Ila Mishra, et al.
Published: (2021-04-01)

Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects
by: Mariam Farrag, et al.
Published: (2023-01-01)

Increased serum asprosin is correlated with diabetes mellitus-induced erectile dysfunction
by: Chun-Hui Li, et al.
Published: (2024-04-01)

Serum asprosin levels in patients with retinopathy of prematurity
by: Yardim Meltem, et al.
Published: (2022-09-01)

Predictive roles of Asprosin and Gremlin-1 expression in Egyptian pediatric patients with type 1 diabetes
by: Al-shimaa M. Abas, et al.
Published: (2025-02-01)

Immunohistochemical Analysis of Asprosin and Meteorin-Like Peptide in Melanocytic Nevus and Malignant Melanoma
by: Betul Demir, et al.
Published: (2025-01-01)

Higher Serum Asprosin Level is Associated with Urinary Albumin Excretion and Renal Function in Type 2 Diabetes
by: Deng X, et al.
Published: (2020-11-01)

Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus
by: Xinyue Zhang, et al.
Published: (2020-03-01)

Acute Anaerobic Exercise Affects the Secretion of Asprosin, Irisin, and Other Cytokines – A Comparison Between Sexes
by: Magdalena Wiecek, et al.
Published: (2018-12-01)